1. Home
  2. TIL vs VBF Comparison

TIL vs VBF Comparison

Compare TIL & VBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • VBF
  • Stock Information
  • Founded
  • TIL 2018
  • VBF 1970
  • Country
  • TIL United States
  • VBF United States
  • Employees
  • TIL N/A
  • VBF N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • VBF Trusts Except Educational Religious and Charitable
  • Sector
  • TIL Health Care
  • VBF Finance
  • Exchange
  • TIL Nasdaq
  • VBF Nasdaq
  • Market Cap
  • TIL 171.7M
  • VBF 177.3M
  • IPO Year
  • TIL 2021
  • VBF N/A
  • Fundamental
  • Price
  • TIL $17.21
  • VBF $15.42
  • Analyst Decision
  • TIL Buy
  • VBF
  • Analyst Count
  • TIL 5
  • VBF 0
  • Target Price
  • TIL $114.00
  • VBF N/A
  • AVG Volume (30 Days)
  • TIL 85.6K
  • VBF 45.5K
  • Earning Date
  • TIL 03-04-2025
  • VBF 01-01-0001
  • Dividend Yield
  • TIL N/A
  • VBF 5.18%
  • EPS Growth
  • TIL N/A
  • VBF N/A
  • EPS
  • TIL N/A
  • VBF N/A
  • Revenue
  • TIL N/A
  • VBF N/A
  • Revenue This Year
  • TIL N/A
  • VBF N/A
  • Revenue Next Year
  • TIL N/A
  • VBF N/A
  • P/E Ratio
  • TIL N/A
  • VBF N/A
  • Revenue Growth
  • TIL N/A
  • VBF N/A
  • 52 Week Low
  • TIL $9.62
  • VBF $13.68
  • 52 Week High
  • TIL $92.00
  • VBF $16.27
  • Technical
  • Relative Strength Index (RSI)
  • TIL 42.69
  • VBF 52.50
  • Support Level
  • TIL $17.87
  • VBF $15.26
  • Resistance Level
  • TIL $19.61
  • VBF $15.36
  • Average True Range (ATR)
  • TIL 1.68
  • VBF 0.08
  • MACD
  • TIL -0.06
  • VBF 0.03
  • Stochastic Oscillator
  • TIL 5.69
  • VBF 83.87

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About VBF Invesco Bond Fund

Invesco Bond Fund is an independent investment management firm. Its investment objective is to seek interest income while conserving capital.

Share on Social Networks: